加多宝和王老吉的海外"王老吉"商标之争继续发酵。 10月10日，加多宝集团发布关于海外"王老吉"商标所有权的声明称，加多宝集团自上世纪九十年代从王 老吉（正名王泽邦）后人手中取得祖传凉茶秘方及海外王老吉商标使用权，并于2000年初合法获得海外 王老吉商标所有权。 声明提及，为了让更多消费者认识中国的凉茶品类，加多宝集团积极开拓海外市场，在全球超过60个主 要国家和地区注册王老吉商标，巩固其市场上的地位和品牌形象。通过不断扩展营销渠道，深入市场， 加多宝集团拥有的海外王老吉品牌凉茶至今已远销全世界数十多个国家和地区。 二是关于加多宝集团蓄意误导"王老吉"境外商标的情况，王老吉称，加多宝集团所谓"侵权、假冒、不 正当竞争"的表述，是对商标法律定义的误读与误导，其通过海外离岸关联公司万捷有限公司在全球60 余个国家和地区进行恶意注册，干扰公司正常拓展海外业务。针对加多宝集团的上述恶意行径，王老吉 坚决采取维权行动。在中国澳门、中国台湾、澳大利亚、巴西、韩国、日本、德国、法国、新西兰等21 个国家/地区，以商标不使用撤销、商标无效宣告的程序对其恶意注册行为进行打击。现已有10个国家/ 地区的审理机关作出撤销其商标的决 ...

Core Viewpoint - The ongoing trademark dispute between Jia Duo Bao Group and Wang Lao Ji has escalated, with both companies making conflicting claims regarding the ownership and registration of the Wang Lao Ji brand internationally [1][2]. Group 1: Trademark Ownership and Dispute - Jia Duo Bao Group claims to have acquired the secret recipe and overseas trademark rights for Wang Lao Ji in the 1990s, and asserts ownership of the overseas brand, which has been exported to over 10 countries and regions [1]. - Wang Lao Ji has accused Jia Duo Bao Group of maliciously registering the Wang Lao Ji trademark in over 60 major countries, hindering its overseas business expansion [1]. - Wang Lao Ji is currently taking legal action in 21 countries and regions, including Macau and Taiwan, against Jia Duo Bao's alleged malicious trademark registrations, with 10 of these regions already deciding to revoke Jia Duo Bao's trademarks [1]. Group 2: Historical Context and Legal Proceedings - The relationship between Wang Lao Ji and Jia Duo Bao was once collaborative, with Jia Duo Bao operating Wang Lao Ji as the leading herbal tea brand until 2012, when the trademark authorization was revoked by Wang Lao Ji's parent company, Guangzhou Pharmaceutical Group [1]. - Following the revocation, both companies have engaged in prolonged litigation over patent rights, trademark rights, and advertising slogans, leading to a series of price wars in the market [1]. - In 2018, Jia Duo Bao announced the cessation of the price war, and the final rulings on the patent and advertising disputes were anticipated, suggesting a potential resolution to their ongoing conflict [2]. - However, the trademark litigation remains unresolved as Jia Duo Bao continues to appeal the unfavorable rulings [2].

Core Viewpoint - The ongoing trademark dispute between Jia Duo Bao and Wang Lao Ji has escalated, focusing on the overseas trademark ownership of "Wang Lao Ji" as both companies compete in international markets [2][10]. Group 1: Trademark Dispute - Wang Lao Ji accused Jia Duo Bao of maliciously registering the "Wang Lao Ji" trademark through offshore companies [2][10]. - Jia Duo Bao claims to have legally obtained the overseas trademark ownership in the 2000s and has registered it in over 60 countries [6][10]. - Both companies cite different court rulings to support their claims, highlighting contrasting legal interpretations [10][11]. Group 2: Market Competition - The trademark dispute coincides with Wang Lao Ji's launch of the "WALOVI" brand for international markets, intensifying competition [9][10]. - The global plant-based beverage market is experiencing significant growth, with a projected compound annual growth rate of nearly 10% from 2019 to 2024, making it a new battleground for domestic brands [14]. - Wang Lao Ji's overseas market revenue has increased 6.5 times over the past decade, with a compound annual growth rate exceeding 25% [14]. Group 3: Financial Performance - Wang Lao Ji's parent company, Baiyun Mountain, reported a 8.38% year-on-year increase in revenue to 6.499 billion yuan and a 15.87% increase in net profit to 1.295 billion yuan in the first half of 2025 [14]. - Jia Duo Bao is also expanding its overseas presence, particularly in Southeast Asia and Hong Kong, and has established a factory in Malaysia [14].

【导读】因 "王老吉"海外商标归属权， 加多宝与王老吉再度开战 见习记者 夏天 曾因 "王老吉" 商标缠斗多年的 加多宝 集团（以下简称加多宝）和广州王老吉大健康产业有 限公司（以下简称 王老吉 ）日前再度交锋，这次事关 "王老吉"海外商标归属权。 9月30日，王老吉发布声明，指责加多宝通过海外离岸公司进行恶意注册"王老吉"境外商标。 对此，加多宝10月10日发布声明予以反击。公司表示，其在2000年代合法取得海外"王老 吉"商标所有权，目前已在全球60个主要国家和地区注册了"王老吉"商标。 对此，王老吉方面回应称，已在21个国家/地区对加多宝关联公司的商标注册行为发起维权挑 战，其中10个国家/地区的审理机关已作出撤销加多宝商标的决定。王老吉特别指出，澳门特 别行政区终审法院在判决书中明确表示：若商标注册仅为"排除他人使用"而保留权利，即便 象征性使用，也不构成"认真使用"要件，因此其商标应予撤销。 商标争夺战持续多年 这场争议正值 王老吉推出"WALOVI"标识国际罐 加速出海之际，双方在海外市场的竞争再度 升温。 打响海外商标争夺战 加多宝与王老吉针对"王老吉"海外商标归属问题正展开"唇枪舌战"。 10 ...

Core Viewpoint - The ongoing dispute between Jia Duo Bao Group and Wang Lao Ji Health Industry Company regarding the ownership of the Wang Lao Ji overseas trademark has escalated, with both parties making conflicting claims about their rights and registrations in international markets [1][5]. Group 1: Jia Duo Bao Group's Position - Jia Duo Bao Group asserts that it acquired the Wang Lao Ji trademark rights and the secret recipe for herbal tea from the descendants of Wang Ze Bang in the 1990s and legally obtained the overseas trademark ownership in the early 2000s [2][3]. - The company claims to have registered the Wang Lao Ji trademark in over 60 major countries and regions globally, emphasizing its commitment to promoting Chinese herbal tea culture worldwide [2][3]. - Jia Duo Bao Group intends to take legal action to protect its rights against any infringement or disruption to its market position, asserting that it will not tolerate any actions that harm its reputation or legal rights [2][3]. Group 2: Wang Lao Ji Health Industry Company's Position - Wang Lao Ji Health Industry Company claims that the true owner of the Wang Lao Ji trademark is Guangzhou Baiyunshan Pharmaceutical Holdings Company and accuses Jia Duo Bao Group of maliciously registering the trademark through offshore companies, disrupting its overseas business expansion [5][9]. - The company has initiated legal actions in 21 countries/regions to challenge Jia Duo Bao Group's trademark registrations, with 10 jurisdictions already ruling in favor of Wang Lao Ji Health Industry Company by revoking Jia Duo Bao Group's trademarks [9][10]. - Wang Lao Ji Health Industry Company emphasizes its commitment to promoting the Wang Lao Ji brand globally, introducing the English brand "WALOVI" to penetrate the international health beverage market [11][12]. Group 3: Market Context and Financial Performance - The competition between Jia Duo Bao and Wang Lao Ji is driven by the need to capture overseas market share, especially as the domestic beverage market becomes increasingly competitive [14][15]. - Wang Lao Ji Health Industry Company reported a revenue of 6.5 billion yuan in the first half of 2025, reflecting an 8.4% year-on-year increase, with a net profit of approximately 1.3 billion yuan, up 15.8% [14]. - The overseas market for Wang Lao Ji has seen significant growth, with a 6.5-fold increase in scale over the past decade and a compound annual growth rate exceeding 25% [14].

Core Viewpoint - The meeting between the Uzbek Consul General and Guangzhou Pharmaceutical Group highlights potential collaboration in various sectors, including trade, drug development, and traditional medicine exchange [1] Group 1: Company Activities - Guangzhou Pharmaceutical Group hosted a visit from the Uzbek Consul General, Sultanbek Imamov, along with representatives from its subsidiaries, including Tianxin Pharmaceutical and Wanglaoji Health [1] - Tianxin Pharmaceutical and Wanglaoji Health presented their overseas expansion efforts during the meeting [1] Group 2: Areas of Cooperation - The discussions focused on multiple areas of cooperation, such as bilateral trade of products, innovative drug research and development, investment in manufacturing facilities in Central Asia, and exchanges in traditional medicine [1]

Core Viewpoint - The dispute between Jia Duo Bao Group and Wang Lao Ji Health Industry Company regarding the ownership of the overseas Wang Lao Ji trademark has escalated, with both parties claiming rights and accusing each other of malicious registration [1][2][6]. Group 1: Jia Duo Bao Group's Position - Jia Duo Bao Group asserts that it obtained the overseas Wang Lao Ji trademark rights in the early 2000s after acquiring the secret recipe from the descendants of Wang Lao Ji in the 1990s, and has since registered the trademark in over 60 countries [2][3]. - The company emphasizes its commitment to promoting Chinese herbal tea culture globally and plans to take legal action to protect its trademark rights against any infringement [3][4]. - Jia Duo Bao Group aims to maintain high-quality beverage production and expand its market presence, reinforcing its brand image internationally [4]. Group 2: Wang Lao Ji Health Industry Company's Position - Wang Lao Ji Health Industry Company claims that the rightful owner of the Wang Lao Ji trademark is Guangzhou Baiyunshan Pharmaceutical Group, which has registered the trademark in over 100 countries [6][9]. - The company accuses Jia Duo Bao Group of maliciously registering the trademark through offshore companies, disrupting its international business expansion [10][11]. - Wang Lao Ji Health Industry Company has initiated legal actions in various countries to challenge Jia Duo Bao Group's trademark registrations, with some cases already resulting in the cancellation of these registrations [10][11]. Group 3: Legal and Market Implications - The ongoing trademark dispute highlights the complexities of brand ownership and competition in the beverage industry, particularly in the context of international markets [10][11]. - Both companies are actively pursuing legal avenues to assert their claims, indicating a significant potential impact on their respective market strategies and brand positioning [10][11][13].

Core Viewpoint - The trademark dispute between Jia Duo Bao and Wang Lao Ji has intensified, with both parties claiming ownership of the overseas trademark rights for "Wang Lao Ji" [3][5]. Trademark Ownership Claims - Jia Duo Bao claims to have acquired the overseas trademark rights in the 2000s and has registered the trademark in 60 countries [3]. - Wang Lao Ji Da Jian Kang Company asserts that the trademark belongs to Guangzhou Baiyunshan Pharmaceutical Holdings Company and has registered the trademark in over 100 countries [5]. Legal Actions and Market Impact - Both companies are engaged in legal battles, with Jia Duo Bao claiming victories in multiple lawsuits, while Wang Lao Ji Da Jian Kang has initiated actions in 21 countries against Jia Duo Bao's alleged malicious registrations [5][6]. - The ongoing trademark conflict is seen as a strategic move to gain dominance in the overseas market, which is crucial for growth amid intense domestic competition [6]. Financial Performance - In the first half of 2025, Wang Lao Ji Da Jian Kang reported revenues of 6.5 billion yuan, an 8.4% increase year-on-year, with a net profit of approximately 1.3 billion yuan, up 15.8% [7]. - The overseas market for Wang Lao Ji has grown 6.5 times over the past decade, with a compound annual growth rate exceeding 25% [7]. Market Dynamics - The competition between Jia Duo Bao and Wang Lao Ji is expected to continue, with Jia Duo Bao having an early advantage in overseas markets, while Wang Lao Ji maintains significant brand influence [7].

Core Viewpoint - The trademark dispute over "Wanglaoji" has intensified, with both JDB Group and Guangzhou Wanglaoji Health Industry Co., Ltd. claiming ownership of the overseas trademark rights [1] Group 1: JDB Group's Position - On October 10, JDB Group announced it holds the overseas trademark rights for Wanglaoji, claiming to have acquired the rights from Wanglaoji's descendants in the 1990s [1] - JDB Group asserts that it legally obtained the overseas trademark ownership in the 2000s and has registered the Wanglaoji trademark in 60 major countries and regions worldwide [1] - The company plans to take legal action to protect its rights against what it describes as false claims regarding the overseas Wanglaoji brand rights [1] Group 2: Guangzhou Wanglaoji Health Industry Co., Ltd.'s Position - On September 30, Guangzhou Wanglaoji Health Industry Co., Ltd. accused JDB Group of malicious trademark registration, asserting that the Wanglaoji trademark is owned by Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. [1] - The company claims to have registered the "Wanglaoji" and "WALOVI" series trademarks in over 100 countries and regions globally [1] - It alleges that JDB Group has interfered with its normal overseas business expansion through malicious registrations by offshore affiliates [1]

Core Viewpoint - The trademark dispute over the "Wang Lao Ji" brand has escalated into an international battle, with both Jia Duo Bao Group and Wang Lao Ji Health Industry Company claiming ownership of the overseas trademark rights, highlighting the strategic importance of brand recognition in expanding into overseas markets [1][3][4]. Trademark Ownership Claims - Jia Duo Bao Group asserts that it acquired the overseas trademark rights in the 1990s and has registered the "Wang Lao Ji" trademark in 60 countries and regions [1]. - Wang Lao Ji Health Industry Company claims that the trademark owner is Guangzhou Baiyunshan Pharmaceutical Group and has registered the "Wang Lao Ji" and "WALOVI" trademarks in over 100 countries [3]. Legal Actions and Market Impact - Both companies are engaged in legal battles, with Jia Duo Bao claiming victories in multiple lawsuits in Canada and the EU, while Wang Lao Ji has initiated actions in 21 countries against Jia Duo Bao's alleged malicious registrations [3][4]. - The ongoing trademark dispute is seen as a strategic move to gain dominance in the overseas market, which is crucial for both companies as domestic competition intensifies [4]. Financial Performance - Wang Lao Ji Health Industry Company reported a revenue of 6.5 billion yuan in the first half of 2025, an increase of 8.4% year-on-year, with a net profit of approximately 1.3 billion yuan, up 15.8% [4]. - The company's revenue figures from 2022 to 2024 were 9.35 billion, 10.01 billion, and 8.76 billion yuan, respectively, indicating fluctuations in performance [4]. - Over the past decade, Wang Lao Ji's overseas market size has grown 6.5 times, with an annual compound growth rate exceeding 25% [4].